ADHD Drugs To Have Stronger Warning; Include Novartis International AG's Dexedrine And GlaxoSmithKline Biologicals's Ritalin

Published: Aug 22, 2006

WASHINGTON (AP) -- The Food and Drug Administration on Monday announced changes to the labels for Dexedrine, an amphetamine used to treat attention-deficit hyperactivity disorder and narcolepsy, to warn of possible heart problems it may cause.

>>> Discuss This Story

Back to news